Median proGRP concentrations were in the range of 30-40 and 50-70 ng/L in case of early-stage lung cancer, NET aside, and pneumonia or COPD, respectively (Table 2 and Figure 1A). This evidence concerns the gene GRP and susceptibility to pneumonia measurement.